Melon-grace Psychological Services | |
911 N Elm St Suite 316 Hinsdale IL 60521-3634 | |
(630) 920-9113 | |
Not Available |
Full Name | Melon-grace Psychological Services |
---|---|
Speciality | Psychologist |
Location | 911 N Elm St, Hinsdale, Illinois |
Authorized Official Name and Position | William Melon (PRESIDENT) |
Authorized Official Contact | 6309209113 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Melon-grace Psychological Services 911 N Elm St Suite 316 Hinsdale IL 60521-3634 Ph: (630) 920-9113 | Melon-grace Psychological Services 911 N Elm St Suite 316 Hinsdale IL 60521-3634 Ph: (630) 920-9113 |
NPI Number | 1053448662 |
---|---|
Provider Enumeration Date | 02/28/2007 |
Last Update Date | 09/18/2008 |
Medicare PECOS PAC ID | 8325107444 |
---|---|
Medicare Enrollment ID | O20081104000779 |
News Archive
The impaired substrate metabolism of diabetes patients is often expressed in an increase in fatty deposits in the cells of the heart muscle. Until now, the exact cause of this was unknown. Now, researchers at the MedUni Vienna in the Division of Endocrinology and Metabolism of MedUni Vienna in cooperation with the MR Centre of Excellence Vienna have shown that high blood sugar in combination with high levels of insulin - not an influx of fats - results in such deposits within a few hours.
A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The vaccine BM32 is based on an innovative recombinant peptide carrier technology that allows for fewer injections and shows fewer side effects compared with other immunotherapy treatments for allergy sufferers. BM32 has been developed by Biomay AG, an Austrian biopharmaceutical company specialized in the discovery and development of innovative allergy therapeutics. The company has already initiated a Phase IIb trial for BM32 with 180 allergic patients.
Federal Parliamentary Secretary for Health Mark Butler has announced that following public concern and a safety review ordered by US health regulators, the phase out will begin from today. He also revealed that according to Food Standards Australia New Zealand intake levels are very low and do not pose a risk to babies' health.
GOP presidential hopeful Mitt Romney offered his support for the plan advanced by Rep. Paul Rayn, R- Wis., causing Democrats to point out inconsistencies with his attacks on the health law. Meanwhile, Democrats have posted a billboard in Ryan's hometown criticizing his proposals on Medicare.
Addfield now own and control the complete range of Techtrol "Pyrotec" branded incinerator/ cremator designs, websites/ marketing data along with all other general goodwill and IP of the business.
› Verified 7 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1053448662 | NPI | - | NPPES |
0001605025 | Other | IL | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 060007829 (Illinois) | Primary |
Provider Name | William H Melon |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1265569883 PECOS PAC ID: 3870652902 Enrollment ID: I20081104000787 |
News Archive
The impaired substrate metabolism of diabetes patients is often expressed in an increase in fatty deposits in the cells of the heart muscle. Until now, the exact cause of this was unknown. Now, researchers at the MedUni Vienna in the Division of Endocrinology and Metabolism of MedUni Vienna in cooperation with the MR Centre of Excellence Vienna have shown that high blood sugar in combination with high levels of insulin - not an influx of fats - results in such deposits within a few hours.
A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The vaccine BM32 is based on an innovative recombinant peptide carrier technology that allows for fewer injections and shows fewer side effects compared with other immunotherapy treatments for allergy sufferers. BM32 has been developed by Biomay AG, an Austrian biopharmaceutical company specialized in the discovery and development of innovative allergy therapeutics. The company has already initiated a Phase IIb trial for BM32 with 180 allergic patients.
Federal Parliamentary Secretary for Health Mark Butler has announced that following public concern and a safety review ordered by US health regulators, the phase out will begin from today. He also revealed that according to Food Standards Australia New Zealand intake levels are very low and do not pose a risk to babies' health.
GOP presidential hopeful Mitt Romney offered his support for the plan advanced by Rep. Paul Rayn, R- Wis., causing Democrats to point out inconsistencies with his attacks on the health law. Meanwhile, Democrats have posted a billboard in Ryan's hometown criticizing his proposals on Medicare.
Addfield now own and control the complete range of Techtrol "Pyrotec" branded incinerator/ cremator designs, websites/ marketing data along with all other general goodwill and IP of the business.
› Verified 7 days ago
News Archive
The impaired substrate metabolism of diabetes patients is often expressed in an increase in fatty deposits in the cells of the heart muscle. Until now, the exact cause of this was unknown. Now, researchers at the MedUni Vienna in the Division of Endocrinology and Metabolism of MedUni Vienna in cooperation with the MR Centre of Excellence Vienna have shown that high blood sugar in combination with high levels of insulin - not an influx of fats - results in such deposits within a few hours.
A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The vaccine BM32 is based on an innovative recombinant peptide carrier technology that allows for fewer injections and shows fewer side effects compared with other immunotherapy treatments for allergy sufferers. BM32 has been developed by Biomay AG, an Austrian biopharmaceutical company specialized in the discovery and development of innovative allergy therapeutics. The company has already initiated a Phase IIb trial for BM32 with 180 allergic patients.
Federal Parliamentary Secretary for Health Mark Butler has announced that following public concern and a safety review ordered by US health regulators, the phase out will begin from today. He also revealed that according to Food Standards Australia New Zealand intake levels are very low and do not pose a risk to babies' health.
GOP presidential hopeful Mitt Romney offered his support for the plan advanced by Rep. Paul Rayn, R- Wis., causing Democrats to point out inconsistencies with his attacks on the health law. Meanwhile, Democrats have posted a billboard in Ryan's hometown criticizing his proposals on Medicare.
Addfield now own and control the complete range of Techtrol "Pyrotec" branded incinerator/ cremator designs, websites/ marketing data along with all other general goodwill and IP of the business.
› Verified 7 days ago
Alexandra Petrohilos Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 19 N Grant St, Suite Lc, Hinsdale, IL 60521 Phone: 630-286-2785 | |
Hinsdale Psychological Resources, Ltd. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 333 Chestnut St, Ste 206, Hinsdale, IL 60521 Phone: 630-850-9650 Fax: 630-850-9607 | |
Heritage Professional Associates Ltd Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 120 E Ogden Ave 220, Hinsdale, IL 60521 Phone: 630-325-5300 Fax: 630-325-5309 | |
Medical Neurology Associates Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 908 N Elm St, 202, Hinsdale, IL 60521 Phone: 630-856-8640 Fax: 630-325-8746 | |
Ces Assoc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 112 South Grant Street, Hinsdale, IL 60521 Phone: 630-654-2596 Fax: 630-654-2596 | |
Mindful Psychiatric Care Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 120 E Ogden Ave Ste 101, Hinsdale, IL 60521 Phone: 630-366-7330 |